161 related articles for article (PubMed ID: 32804707)
21. Operative management of metastatic melanoma in bone may require en bloc resection of disease.
Krygier JE; Lewis VO; Cannon CP; Satcher RL; Moon BS; Lin PP
Clin Orthop Relat Res; 2014 Oct; 472(10):3196-203. PubMed ID: 24989125
[TBL] [Abstract][Full Text] [Related]
22. Metastatic patterns, clinical outcome, and malignant phenotype in malignant cutaneous melanoma.
Cohn-Cedermark G; Månsson-Brahme E; Rutqvist LE; Larsson O; Singnomklao T; Ringborg U
Acta Oncol; 1999; 38(5):549-57. PubMed ID: 10427942
[TBL] [Abstract][Full Text] [Related]
23. Primary melanoma location on the scalp is an important risk factor for brain metastasis: a study of 1,687 patients with cutaneous head and neck melanomas.
Huismans AM; Haydu LE; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Thompson JF
Ann Surg Oncol; 2014 Nov; 21(12):3985-91. PubMed ID: 24912613
[TBL] [Abstract][Full Text] [Related]
24. Clinical and histological features of poor prognosis in cutaneous metastatic melanomas.
Hofmann-Wellenhof R; Woltsche-Kahr I; Smolle J; Kerl H
J Cutan Pathol; 1996 Jun; 23(3):199-204. PubMed ID: 8793653
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic features and behavior of cutaneous eyelid melanoma.
Vaziri M; Buffam FV; Martinka M; Oryschak A; Dhaliwal H; White VA
Ophthalmology; 2002 May; 109(5):901-8. PubMed ID: 11986095
[TBL] [Abstract][Full Text] [Related]
26. Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastases.
Kakavand H; Vilain RE; Wilmott JS; Burke H; Yearley JH; Thompson JF; Hersey P; Long GV; Scolyer RA
Mod Pathol; 2015 Dec; 28(12):1535-44. PubMed ID: 26403784
[TBL] [Abstract][Full Text] [Related]
27. Sex differences in survival from cutaneous melanoma.
Rampen FH
Int J Dermatol; 1984 Sep; 23(7):444-52. PubMed ID: 6386712
[TBL] [Abstract][Full Text] [Related]
28. Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors.
Waninger JJ; Ma VT; Journey S; Skvarce J; Chopra Z; Tezel A; Bryant AK; Mayo C; Sun Y; Sankar K; Ramnath N; Lao C; Sussman JB; Fecher L; Alva A; Green MD
JAMA Netw Open; 2021 Mar; 4(3):e210980. PubMed ID: 33687443
[TBL] [Abstract][Full Text] [Related]
29. Decreased expression of hyaluronan synthase 1 and 2 associates with poor prognosis in cutaneous melanoma.
Poukka M; Bykachev A; Siiskonen H; Tyynelä-Korhonen K; Auvinen P; Pasonen-Seppänen S; Sironen R
BMC Cancer; 2016 May; 16():313. PubMed ID: 27184066
[TBL] [Abstract][Full Text] [Related]
30. Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.
Kuk D; Shoushtari AN; Barker CA; Panageas KS; Munhoz RR; Momtaz P; Ariyan CE; Brady MS; Coit DG; Bogatch K; Callahan MK; Wolchok JD; Carvajal RD; Postow MA
Oncologist; 2016 Jul; 21(7):848-54. PubMed ID: 27286787
[TBL] [Abstract][Full Text] [Related]
31. Independent prognostic importance of vascular invasion in nodular melanomas.
Straume O; Akslen LA
Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients.
Tan SY; Najita J; Li X; Strazzulla LC; Dunbar H; Lee MY; Seery VJ; Buchbinder EI; Tawa NE; McDermott DF; Lee SJ; Atkins MB; Kim CC
Melanoma Res; 2019 Feb; 29(1):70-76. PubMed ID: 30169431
[TBL] [Abstract][Full Text] [Related]
33. Histological lymphovascular invasion is associated with nodal involvement, recurrence, and survival in patients with cutaneous malignant melanoma.
Tas F; Erturk K
Int J Dermatol; 2017 Feb; 56(2):166-170. PubMed ID: 27778319
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous melanoma: prognosis and treatment results worldwide.
Balch CM
Semin Surg Oncol; 1992; 8(6):400-14. PubMed ID: 1439450
[TBL] [Abstract][Full Text] [Related]
35. Survival with regional and distant metastases from cutaneous malignant melanoma.
Roses DF; Karp NS; Oratz R; Dubin N; Harris MN; Speyer J; Boyd A; Golomb FM; Ransohoff J; Dugan M
Surg Gynecol Obstet; 1991 Apr; 172(4):262-8. PubMed ID: 2006449
[TBL] [Abstract][Full Text] [Related]
36. Surgical treatment of skeletal metastases in 31 melanoma patients.
Wedin R; Falkenius J; Weiss RJ; Hansson J
Acta Orthop Belg; 2012 Apr; 78(2):246-53. PubMed ID: 22696997
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in young women with cutaneous melanoma.
Burton AL; Egger ME; Quillo AR; Stromberg AJ; Hagendoorn L; Scoggins CR; Martin RC; McMasters KM; Callender GG
Am J Surg; 2014 Jan; 207(1):102-8. PubMed ID: 24330977
[TBL] [Abstract][Full Text] [Related]
38. Time course and pattern of metastasis of cutaneous melanoma differ between men and women.
Mervic L
PLoS One; 2012; 7(3):e32955. PubMed ID: 22412958
[TBL] [Abstract][Full Text] [Related]
39. [Melanoma and primary hyperparathyroidism].
Maerens-Tchokokam B; Bailly N; Collet E; Dalac S; Rat P; Lambert D
Ann Dermatol Venereol; 1993; 120(3):215-7. PubMed ID: 8239359
[TBL] [Abstract][Full Text] [Related]
40. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II).
Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
Ann Surg; 1981 Mar; 193(3):377-88. PubMed ID: 7212800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
